Hantz Financial Services, Inc. Adma Biologics, Inc. Call Options Transaction History
Hantz Financial Services, Inc.
- $6.19 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ADMA
# of Institutions
400Shares Held
196MCall Options Held
2.08MPut Options Held
1.56M-
Vanguard Group Inc Valley Forge, PA21.4MShares$311 Million0.01% of portfolio
-
Black Rock Inc. New York, NY18.6MShares$271 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA12.8MShares$186 Million0.04% of portfolio
-
State Street Corp Boston, MA12.1MShares$176 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.91MShares$86 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $2.86B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...